GL1X · GenesisL1 explorer

Research workbench

Human CTP synthetase 2 - glutaminase domain in complex with 5-oxo-L-norleucine

Analyse Human CTP synthetase 2 - glutaminase domain in complex with 5-oxo-L-norleucine in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2V4U
Type
protein
Length
267 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
CTP synthase 2
EC
6.3.4.2
UniProt
Q9NRF8
Pockets
3 · best druggability 0.45

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACTP synthase 2 (EC 6.3.4.2)protein26737% helix, 29% strandQ9NRF8

Pockets

3 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1660.450.8216empty
2780.340.7517empty
3720.320.7422empty

Modifications

Observed in the structure: 1 modified (nonstandard).

Compared structures

  • 2V4U · Human CTP synthetase 2 - glutaminase domain in complex with 5-OXO-L- NORLEUCINE · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9NRF8 · AlphaFold monomer V2.0 prediction for CTP synthase 2 (Q9NRF8) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.